IVIRMA

IVIRMA Global stands as the world's leading reproductive medicine group, dedicated to helping women and couples turn their dreams of parenthood into reality. Founded in 1990 by Professors José Remohí and Antonio Pellicer in Valencia, Spain, the organization has grown to become the largest company exclusively devoted to human Assisted Reproduction Technology (ART) worldwide. With over 35 years of experience, IVIRMA has established itself as a benchmark in scientific publication, teaching, and clinical excellence in fertility care.

Today, IVIRMA operates more than 200 clinical offices and 95 laboratories across 15 countries, spanning Europe, Latin America, and the United States. The group welcomes patients from over 180 countries and delivers more than 100 babies daily thanks to their advanced treatments. In 2023 alone, they completed over 180,000 assisted reproductive treatments, maintaining success rates that consistently exceed national averages. The merger of IVI (Europe) and RMA (America) in 2017 created the only global company offering assisted reproduction services across three continents, combining European and American expertise in fertility research and patient care.

IVIRMA's mission extends beyond clinical treatment to encompass research, education, and innovation. Their IVIRMA Innovation division leads scientific research and technology development in reproductive medicine, while their educational institution provides global training programs for medical professionals. The organization is committed to evidence-based fertility solutions with the greatest chance of success, driven by core values of patient-first care, innovation, honesty, and teamwork.